Results 101 to 110 of about 13,637 (222)

Langerhans cell histiocytosis: case report [PDF]

, 2021
Langerhans cells are dendritic cells seen above the basal layer of squamous epithelia. They are cells specialized in the capture of antigens and in the induction of T lymphocyte responses.
Siqueira, Edllanckar dos Santos
core  

Polyostotic Langerhans cell histiocytosis presenting as halitosis in a 24-year-old man: a case report

Journal of Medical Case Reports
Background Langerhans cell histiocytosis is a rare disease of the reticuloendothelial system. This report presents a novel case of Langerhans cell histiocytosis with systemic involvement that started with a simple chief complaint.
Hassan Mirmohammad Sadeghi, Sanaz Gholami Toghchi, Fatemeh Mashhadiabbas, Milad Baseri, Maryam Mohammadalizadeh Chafjiri, Parnian Nikraftar, Ardeshir Khorsand   +6 more
doaj   +1 more source

Langerhans Cell Histiocytosis in a Newborn

Journal of the Chinese Medical Association, 2009
A full-term female baby was admitted to our hospital at the postnatal age of 37 days with generalized vesiculopapular, crateriform skin lesions. Physical examination revealed a well-nourished baby without fever, hepatosplenomegaly or lymphadenopathy. Laboratory examination was normal except for thrombocytosis (platelet count, 970 x 10(3)/microL).
Yang, Tzu-Ying, Chen, Shu-Jen, Yang, Ling-Yu, Tang, Ren-Bin   +3 more
openaire   +2 more sources

Genetic analysis of primary lung interdigitating dendritic cell sarcomas

The Journal of Pathology, Volume 269, Issue 4-5, Page 387-398, August 2026.
Abstract Interdigitating dendritic cell sarcomas (IDCSs) are rare tumors that commonly arise in the hematopoietic system and rarely outside. The genetic drivers of IDCS carcinogenesis are unknown; therefore, therapeutic options are limited. We investigated somatic gene mutations and copy‐number alterations (CNAs) in nine IDCSs arising in the lung by ...
Mikhail S Ermakov, Juliana Faria Filipe, Sylvia Eidenhammer, German Ott, Iris Halbwedl, Karl Kashofer, Helmut Popper   +6 more
wiley   +1 more source

Skull Base Langerhans Cell Histiocytosis with Diabetes Insipidus and Panhypopituitarism- A Rare Clinical Entity

Bengal Journal of Otolaryngology and Head Neck Surgery, 2017
Introduction A case of Langerhans cell histiocytosis (LGH) involving extensive area of base of skull resulting in panhypopituitarism and diabetes insipidus (DI) is reported.
Anirban Ghosh, Mithun Chaudhury, Abhishek Mukherjee   +2 more
doaj   +3 more sources

Doença de células de langerhans e mama.

Acta Médica Portuguesa, 2011
Langerhans cell histiocytosis (LCH) is a rare systemic disorder, with a diversified presentation and natural history. It can compromise any organ. We report a case of a 32-year-old woman who came to our clinic with an asymptomatic palpable breast mass ...
Cátia Rodrigues, Paulo Santos, Dora Simões, Maria Odete Valério, C Calhaz-Jorge   +4 more
doaj   +1 more source

Novel BRAF fusion in Erdheim–Chester disease with pulmonary manifestations: Importance of RNA‐based testing and response to MEK inhibition

Histopathology, EarlyView.
Igor Odintsov, Henry D. Tazelaar, Jerry C. Lee, Lloyd E. Damon, Walter Patrick Devine, Kirk D. Jones   +5 more
wiley   +1 more source

A Rare Case of Cutaneous Crystal‐Storing Histiocytosis With Kappa Light Chain Restriction and Unusual BCL6 Expression

Journal of Cutaneous Pathology, Volume 53, Issue 8, Page 682-686, August 2026.
ABSTRACT Crystal‐storing histiocytosis (CSH) is a rare histopathologic phenomenon characterized by the accumulation of crystalline material within histiocytes, most often associated with lymphoplasmacytic or plasma cell neoplasms. Cutaneous involvement is uncommon and may present diagnostic challenges.
Liangli Wang, Jonathan L. Curry, Julia Dai, Daniel H. Wang, Paolo Strati, Melody R. Becnel, Leomar Y. Ballester, Carlos A. Torres‐Cabala, Phyu P. Aung   +8 more
wiley   +1 more source

Synthetic Ligands of Myeloid C‐Type Lectin Receptors

ChemBioChem, Volume 27, Issue 13, 14 July 2026.
Binding of ligands to C‐type lectin receptors (CLRs) on myeloid cells can lead to an array of cellular responses. Exploitation of these receptors for therapeutic purposes requires high‐affinity ligands. This review surveys the diversity of synthetic ligands of myeloid CLRs in the context of binding, signaling, and downstream effects, as well as ...
James Suri, Bernd Lepenies
wiley   +1 more source

Langerhans cell and non Langerhans cell histiocytosis: So different? [PDF]

, 2007
The Author reports the clinical and laboratory criteria that do not support the strict distinction between Langerhans cell and non Langerhans cell histiocytosis as reported in the relevant ...
C. Gelmetti
core